Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Generation Xers--saving and investing strategy -- Ignore unavailable to you. Want to Upgrade?

To: Billy Bob who wrote (89)	8/12/1998 3:44:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 100

Thanks for your response, it will take me a little while to digest it, but it is interesting that you felt I am backwards in the IRA. Of course when I was trading a lot, and making money last spring, I liked that there were no immediate tax implications. Your point about not being able to take advantage of the losses assumes that I don't sell my gainers for 18 months, yes? Well, I pretty much sold my gainers as soon as they light up. Sorry for the long answer which follows, but you asked! If you don't want to slog through all of this, just go read through the aria and ntii threads, those are my top two picks. But if I were you, I sure wouldn't go by what Mike McFarland has to say--after all, I've been losing money since June! As far as the biotechs I own now...well as that whole sector has gone down this year, I did okay dancing in and out, but now I hold Ariad (ARIA)--I don't understand the science too well, but the chance that they could come up with somthing in the area of asthma and gene therapy is just too exciting to ignore. They are also into other things which make better headlines, cancer research for instance. I also have some of the warrants at 1/4, and some more at 3/8ths--yes, I have a gambling habit, hehe. Anything that I say about it here wont do it justice, you would really do well to read some posts off the thread. read this page too ariad.com I have some NTII, Neuro. Tech., if and when they finally do a deal it will double instantly, well, that is my guess anyway. The truth is that after some basic detective work I came to the conclusion that the market cap of this is so tiny, that it has simply been overlooked by institutional investors, and I'm guessing it is very cheap. Some of the posts on the ntii thread are quite convincing, and I was impressed on the last confernce call. Nothing too flashy, not very sexy, but I feel pretty confident that it has simply been overlooked. Lately, somebody has been accumulating a few shares I think, there were a few handfulls of 10k blocks of shares a couple weeks ago, but mainly it doesn't hardly trade at all. I have some Targeted Genetics--it is local for me, so I can go to meetings, just another biotech crapshoot--but in at 1.6, so that is good. Also Repligen at 1.4, and Genzyme Transgenics at 5.6--the only one that is actually in the black. That pretty much is my self created biotech fund. I started a roth ira this year and put it in the Frankin discovery biotech fund, I don't follow it, but it is down quite a bit percentage-wise. In the last few days I did a couple trades in LGNDW, but since I don't know much about the company and didn't even bother to find out what the exercise price of the warrants was, I decided I was being a moron and got out--even thank goodness.